High seroconversion rates in Trypanosoma cruzi chronic infection treated with benznidazole in people under 16 years in Guatemala

Autor: Lucia Maria Brum-Soares, Selene González, Juan-Carlos Cubides, Carlota Monroy, Leticia Castillo, Pedro Pablo Palma Urrutia, Pedro Albajar Viñas, Iris Burgos

Publikováno v: Revista da Sociedade Brasileira de Medicina Tropical, Vol 49, Iss 6, Pp 721-727
Revista da Sociedade Brasileira de Medicina Tropical, Volume: 49, Issue: 6, Pages: 721-727, Published: DEC 2016
Revista da Sociedade Brasileira de Medicina Tropical v.49 n.6 2016
Revista da Sociedade Brasileira de Medicina Tropical
Sociedade Brasileira de Medicina Tropical (SBMT)
instacron:SBMT

INTRODUCTION: Geographical, epidemiological, and environmental differences associated with therapeutic response to Chagas etiological treatment have been previously discussed. This study describes high seroconversion rates 72 months after benznidazol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5f59dad572f00c41c15b3fb9584a164
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600721&lng=en&tlng=en